AVLN Avalyn Pharma Inc.
Nasdaq · SEC CIK 1540171 · EDGAR
- Bought, last 12 months
- $25.00M 3 purchases by 3 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 15 since 2026-05-01, latest 2026-09-17 16:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LLC | 10% | $10.00M | — |
| Novo Holdings A/S | 10% | $10.00M | — |
| Carroll Jill | Dir | $5.00M | — |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% | — | — |
| FMR LLC | 10%, See Remark 1 | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-05 16:15 | 2026-05-01 | AVLN | Novo Holdings A/S | 10% | C - Cnv Deriv | — | +3.33M | 3.33M | New | — |
| D | 2026-05-05 16:15 | 2026-05-01 | AVLN | Novo Holdings A/S | 10% | P - Purchase | $18.00 | +555.6K | 3.88M | +17% | +$10.00M |
| DMI | 2026-05-05 08:37 | 2026-05-01 | AVLN | FMR LLC | 10%, See Remark 1 | C - Cnv Deriv | — | +2.28M | 2.28M | New | — |
| DMI | 2026-05-01 18:50 | 2026-05-01 | AVLN | Carroll Jill | Dir | C - Cnv Deriv | — | +1.91M | 1.91M | New | — |
| DI | 2026-05-01 18:50 | 2026-05-01 | AVLN | Carroll Jill | Dir | P - Purchase | $18.00 | +277.8K | 2.19M | +15% | +$5.00M |
| DMI | 2026-05-01 18:46 | 2026-05-01 | AVLN | SR ONE CAPITAL MANAGEMENT, LLC | 10% | C - Cnv Deriv | — | +2.75M | 844.3K | New | — |
| DMI | 2026-05-01 18:46 | 2026-05-01 | AVLN | SR ONE CAPITAL MANAGEMENT, LLC | 10% | P - Purchase | $18.00 | +555.6K | 1.12M | +98% | +$10.00M |
| D | 2026-05-01 18:26 | 2026-05-01 | AVLN | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% | C - Cnv Deriv | — | +1.28M | 1.28M | New | — |
Purchase Sale Sale after option exercise All abbreviations